These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Considerations in the drug treatment of parkinsonism (author's transl)]. Hungerbühler JP; Regli F Schweiz Rundsch Med Prax; 1978 Nov; 67(45):1648-57. PubMed ID: 30976 [No Abstract] [Full Text] [Related]
3. The treatment with L-dopa and amantadine in Parkinson's disease. Pendefunda G; Pollingher B; Stefanache F; Gavril A; Oprisan C; Merling M; Nemteanu E; Ciunru M; Koropitzer I Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871 [No Abstract] [Full Text] [Related]
5. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)]. Gerstenbrand F; Grünberger J; Oberhummer I Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920 [No Abstract] [Full Text] [Related]
6. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)]. Gerstenbrand F; Grünberger J; Oberhummer I HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006 [No Abstract] [Full Text] [Related]
8. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle]. Fünfgeld EW Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341 [No Abstract] [Full Text] [Related]
9. Renaissance of amantadine in the treatment of Parkinson's disease. Blanchet PJ; Metman LV; Chase TN Adv Neurol; 2003; 91():251-7. PubMed ID: 12442683 [No Abstract] [Full Text] [Related]
10. Drug management of Parkinson's disease. Kishore A; Snow BJ Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697 [TBL] [Abstract][Full Text] [Related]
11. [Amantadine in the treatment of Parkinson's disease]. Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639 [No Abstract] [Full Text] [Related]
12. [Amantadine therapy of Parkinson's syndrome. Comment on L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsnism"]. Völler G Munch Med Wochenschr; 1972 Jun; 114(22):1066-7. PubMed ID: 5068022 [No Abstract] [Full Text] [Related]
13. Treatment options for early Parkinson's disease. Stacy M; Brownlee HJ Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572 [TBL] [Abstract][Full Text] [Related]
14. Amantadine hydrochloride in the treatment of Parkinson's disease. Nagaswami S; Ranjini R J Kans Med Soc; 1971 Nov; 72(11):465-8. PubMed ID: 5120698 [No Abstract] [Full Text] [Related]
15. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)]. Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522 [No Abstract] [Full Text] [Related]
16. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease. Koziorowski D; Friedman A Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308 [TBL] [Abstract][Full Text] [Related]
18. [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)]. Gründig E; Gerstenbrand F Wien Klin Wochenschr; 1980 Dec; 92(24):868-71. PubMed ID: 7222702 [TBL] [Abstract][Full Text] [Related]
19. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases]. Sigwald J; Raymondeaud C Nouv Presse Med; 1972 Apr; 1(18):1237-9. PubMed ID: 5025538 [No Abstract] [Full Text] [Related]
20. [Drug therapy in Parkinson's disease]. van Hilten JJ; Roos RA Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]